reports
Danone completes the acquisition of Kate Farms, enhancing its U.S. spe...
Danone completes the acquisition of Kate Farms, enhancing its U.S. specialized nutrition offerings Press release – Paris, July 1st, 2025, at 7:00 P.M. CEST Danone completes the acquisition of Kate Farms,enhancing its U.S. specialized nutrition offerings Danone announced today that it has successfully completed the acquisition of a majority stake in Kate Farms, a fast-growing U.S. business and the #1 doctor-recommended plant-based brand in the U.S., offering a wide array of plant-based, organic nutrition products for both medical and everyday needs. By bringing together the Kate Farms, Nu...
Danone finalise l’acquisition de la société Kate Farms, renforçant son...
Danone finalise l’acquisition de la société Kate Farms, renforçant son offre dans la nutrition spécialisée aux États-Unis Communiqué de presse – Paris, le 1er juillet 2025, à 19h00 Danone finalise l’acquisition de la société Kate Farms, renforçant son offre dans la nutrition spécialisée aux États-Unis Danone annonce aujourd’hui la finalisation de l’acquisition d’une participation majoritaire dans Kate Farms, une entreprise américaine en forte croissance, spécialisée dans la nutrition médicale et du quotidien, à base d’ingrédients biologiques d’origine végétale. Kate Farms est la marque vé...
LVMH: Share transactions disclosure
LVMH: Share transactions disclosure Paris, July 1st, 2025 The disclosure of share transactions carried out from June 23rd to June 27th, 2025, was sent to the AMF on July 1st, 2025. As required by current law, this document is publically available and can be consulted on the Company’s website () under the section «regulated information». LVMH LVMH Moët Hennessy Louis Vuitton is represented in Wines and Spirits by a portfolio of brands that includes Moët & Chandon, Dom Pérignon, Veuve Clicquot, Krug, Ruinart, Mercier, Château d’Yquem, Domaine du Clos des Lambrays, Château Cheval Blanc, Col...
LVMH : Déclaration des transactions sur actions propres
LVMH : Déclaration des transactions sur actions propres Paris, le 1 juillet 2025 La déclaration des transactions sur actions propres réalisées du 23 au 27 juin 2025 a été adressée à l’Autorité des Marchés Financiers le 1 juillet 2025. Ce document est tenu à la disposition du public dans les conditions prévues par la réglementation en vigueur et peut être consulté dans la rubrique «information réglementée» du site internet de la Société (). LVMH LVMH Moët Hennessy Louis Vuitton est présent dans les Vins & Spiritueux au travers notamment des Maisons Moët & Chandon, Dom Pérignon, Veuve Clic...
Sanofi: 1 director
A director at Sanofi bought 500 shares at 82.700EUR and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing C...
ASML reports transactions under its current share buyback program
ASML reports transactions under its current share buyback program ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. DateTotal repurchased sharesWeighted average priceTotal repurchased value23-Jun-2518,507€664.34€12,295,00724-Jun-2517,952€684.92€12,295,73125-Jun-2517,460€704.16€12,294,59226-Jun-2517,961€684.56€12,295,37727-Jun-2517,970€684.18€12,294,795 ASML’s current share buyback program was announced on 10 November 2022, and detai...
- Research Department
IBERIAN DAILY 30 JUNE (ANÁLISIS BANCO SABADELL)
NEWS SUMMARY: IBERDROLA, REDEIA. Lower trade and geopolitical risks It was a week of gains on European stock markets, underpinned by the ceasefire between Israel and Iran and the expectations of a trade agreement with the US. Thus, in the STOXX 600, the best-performing sectors on the week were Construction and Travel & Leisure, whereas Food and Energy ended with the biggest drops. On the macro side, in the euro zone June’s economic confidence index worsened unexpectedly. In Spain, June’s prelim...
- Research Department
INFORME DIARIO 30 JUNIO (ANÁLISIS BANCO SABADELL)
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: IBERDROLA, REDEIA. EUROPA: KERING Menores riesgos comerciales y geopolíticosSemana de ganancias en los índices europeos, apoyados por el alto al fuego entre Israel e Irán y las expectativas de acuerdo comercial con EE.UU. Así, en el STOXX 600 los mejores sectores de la semana fueron Construcción y Viajes&Ocio mientras que Alimentación y Energía terminaron con las mayores caídas. Por el lado macro, en la Eurozona el índice de confianza económica de ju...
Communiqué de presse : Mise en ligne du document «Q2 2025 Aide mémoire...
Communiqué de presse : Mise en ligne du document «Q2 2025 Aide mémoire » Mise en ligne du document «Q2 2025 Aide mémoire » Paris, France, le 30 juin 2025. Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « Q2 2025 Aide mémoire ». Comme chaque trimestre, ce document vise à assister la communauté financière dans la modélisation des résultats trimestriels de la société. Ce document contient un rappel de divers éléments non récurrents, l’effet des variations monétaires et le nombre d’actions. Les résultats du premier tri...
Press release: Availability of the Q2 2025 Aide mémoire
Press release: Availability of the Q2 2025 Aide mémoire Availability of the Q2 2025 Aide mémoire Paris, France – June 30, 2025. Sanofi announced today that its Q2 2025 Aide mémoire is available on the "Investors" page of the company's website: As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document includes a reminder on various non-comparable items, as well as the foreign currency impact and share count. Sanofi's second quarter 2025 results will be published on July 31, 2025. About Sanofi...
Press Release: Riliprubart granted orphan drug designation in Japan fo...
Press Release: Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy Two phase 3 studies are currently underway testing riliprubart in people with CIDP as a potential first-in-class treatmentJapanese Ministry of Health, Labour and Welfare decision adds to similar designations in the US and Europe, underscoring global regulatory recognition of the potential for riliprupart to address significant unmet medical needs for people living...
Communiqué de presse : Le riliprubart obtient la désignation de médica...
Communiqué de presse : Le riliprubart obtient la désignation de médicament orphelin au Japon pour la polyneuropathie inflammatoire démyélinisante chronique Le riliprubart obtient la désignation de médicament orphelin au Japon pour la polyneuropathie inflammatoire démyélinisante chronique Deux études de phase 3 sont actuellement en cours pour tester le riliprubart chez les personnes atteintes de PIDC comme traitement potentiel meilleur de sa catégorieLa décision du ministère de la Santé, du Travail et des Affaires sociales du Japon s’ajoute aux désignations similaires aux États-Unis et en ...
- Pierre FerraguÊ
Deep dive into Chinese Semicap: How much of a headwind for Western pla...
Chinese WFE spending quadrupled in five years to $41bn, driven by aggressive local deployments, while domestic vendors rapidly gained traction, capturing 13% of local spending already, mostly in deposition, etch, and CMP. In this deep dive, we assess the competitiveness of key Chinese vendors, including Naura, AMEC, and SiCarrier. We estimate first the pace (and the scope) at (and on) which they could close the gap with their western peers. On that basis we estimate the share they can gain ov...
- Research Department
INFORME DIARIO 27 JUNIO (ANÁLISIS BANCO SABADELL)
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: IBERDROLA, OHLA, REDEIA, REPSOL. El mercado de divisas, nuevo foco de atención Jornada mixta en las bolsas europeas, que cotizaron divididas con la vista puesta en el dólar y el nuevo retroceso que sufrió ayer, cayendo a mínimos de 2022. En el STOXX 600 R. Básicos e Industriales fueron los sectores que más subieron, frente a las mayores caídas de Hogar y B. de Consumo (sectores con bastante exposición a dólar). Por el lado macro, en EE.UU. el PIB 1...
- Research Department
IBERIAN DAILY 27 JUNE (ANÁLISIS BANCO SABADELL)
NEWS SUMMARY: IBERDROLA, OHLA, REDEIA, REPSOL. Spotlight now on the currency market It was a mixed session on European stock markets, which were a mixed bag with all eyes on the dollar and the drop it suffered yesterday, falling to a low since 2022. In the STOXX 600, Basic Materials and Industrials were the sectors rising the most, with Household Goods and Consumer Goods falling the most (sectors highly exposed to the USD). On the macro side, in the US the 1Q’25 GDP was lowered in its third rea...
Danone further invests in gut health and next-generation biotic resear...
Danone further invests in gut health and next-generation biotic research with the acquisition of The Akkermansia Company Press release – Paris, June 25, 2025, at 18:00 CEST Danone further invests in gut health and next-generation biotic research with the acquisition of The Akkermansia Company Danone today announces the acquisition of The Akkermansia Company (TAC), a Belgian company with nearly 20 years of history and science, specializing in biotics. In 2004, using state-of-the-art technology, scientists at TAC discovered and developed a biotic strain, Akkermansia muciniphila MucT™. The...
Danone renforce son engagement dans la santé intestinale et la recherc...
Danone renforce son engagement dans la santé intestinale et la recherche dans le domaine des biotiques de nouvelle génération avec l’acquisition de The Akkermansia Company Communiqué de presse – Paris, le 25 juin 2025 à 18h00 Danone renforce son engagement dans la santé intestinale et la recherche dans le domaine des biotiques de nouvelle génération avec l’acquisition de The Akkermansia Company Danone annonce aujourd’hui l’acquisition de The Akkermansia Company (TAC), une entreprise belge pionnière dans le domaine de la biotique, forte de près de 20 ans d’expertise et de recherche scienti...
- Research Department
IBERIAN DAILY 25 JUNE (ANÁLISIS BANCO SABADELL)
NEWS SUMMARY: ACCIONA/ACCIONA ENERGÍA, AMPER, IBERDROLA, NEINOR HOMES. Stock markets looking to return to 2025 highs The ceasefire between Iran and Israel continued to fuel stock markets at both sides of the Atlantic, with the Ibex returning to 14,000 points. Thus, in the STOXX 600, all sectors except Energy (due to the drop in oil prices) saw gains, led by Travel&Leisure and Construction. On the macro side, in Germany the IFO index climbed slightly more than expected for the sixth consecutive ...
- Research Department
INFORME DIARIO 25 JUNIO (ANÁLISIS BANCO SABADELL)
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACCIONA, ACCIONA ENERGÍA, AMPER, IBERDROLA, NEINOR HOMES. Las bolsas con ganas de volver a los máximos del año El alto el fuego entre Irán e Israel siguió impulsando las bolsas a ambos lados del Atlántico, con el Ibex recuperando los 14.000 puntos. En el STOXX 600 todos los sectores menos Energía (por la caída del precio del petróleo) subieron, liderados por Viajes&Ocio y Construcción. Por el lado macro, en Alemania el IFO repuntó ligeramente más d...
Press Release: Riliprubart earns orphan drug designation in the US for...
Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation Ongoing phase 2 study evaluating riliprubart for the potential prevention and treatment of active antibody-mediated rejection in kidney transplant recipientsRiliprubart was also designated orphan drug for the investigational use in chronic inflammatory demyelinating polyneuropathy in the US and EU Paris, June 25, 2025. The US Food and Drug Administ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.